Wealth Watch Advisors’s Teladoc Health TDOC Stock Holding History

Wealth Watch Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50	Closed	-$350	–	780
2025 Q4	$350	Hold	50	–	–	﹤0.01%	900
2025 Q3	$387	Buy	+50	New	+$390	﹤0.01%	871

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealth Watch Advisors's TDOC Position: Q1 2026 in Review

Wealth Watch Advisors sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 50 shares — an estimated $350 sold.

Wealth Watch Advisors first reported a position in TDOC in Q3 2025 and held it in 2 quarters. The position peaked at $387 in Q3 2025. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Wealth Watch Advisors reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
Wealth Watch Advisors sold 50 Teladoc Health shares in Q1 2026, an estimated $350.
Wealth Watch Advisors first reported a position in Teladoc Health in Q3 2025 and held it in 2 quarters.
Wealth Watch Advisors's Teladoc Health position peaked at $387 in Q3 2025.
322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Wealth Watch Advisors's 13F filing for Q1 2026, filed 15 May 2026.